Freshfields Bruckhaus Deringer (‘Freshfields’) advised Hasten Biopharmaceuticals on the acquisition. Hasten Biopharmaceuticals, a leading specialty pharmaceutical company based in China and a portfolio company of CBC...
Hasten Biopharmaceuticals’ Acquisition of 14 Product Portfolios from Celltrion Healthcare
Dalian Wanda Commercial Management’s $8.3bn Investment Agreement with Zhuhai Wanda Commercial Management
Freshfields advised Dalian Wanda Commercial Management on capital restructuring and US$8.3bn investment in Zhuhai Wanda Commercial Management. Dalian Wanda Commercial Management Group (hereafter referred to as...
Volkswagen Group €2.4bn Investment in Chinese Joint Venture with Horizon Robotics
Freshfields Bruckhaus Deringer (‘Freshfields’) advised Volkswagen Group on €2.4bn investment in China smart vehicle technology joint venture with Horizon Robotics. Volkswagen Group (through its subsidiary CARIAD)...
Röhm’s Acquisition of SABIC’s Functional Forms Business
Freshfields Bruckhaus Deringer advised Röhm on the deal. Röhm, one of the leading manufacturers in the methacrylates business, executed its acquisition of SABIC’s Functional Forms business....
Huadong’s Strategic Partnership With Heidelberg Pharma
Freshfields and Greenberg Traurig advised Huadong on the deal. GÖRG Partnerschaft von Rechtsanwälten advised Heidelberg Pharma AG. RITTERSHAUS advised dievini. Huadong Medicine Co Ltd, based in...
Huadong’s Strategic Partnership With Heidelberg Pharma
IN BRIEF: Freshfields Bruckhaus Deringer LLP, advised on the matter. Freshfields Bruckhaus Deringer LLP advised Huadong Medicine Co Ltd with a team including Jan Brinkmann (Tax...
Shenzhen Mindray Bio-Medical Electronics’ €545 Million Acquisition Of Hytest Invest Oy
Freshfields Bruckhaus Deringer advised Shenzhen Mindray Bio-Medical Electronics Co., Ltd. on the deal. Shenzhen Mindray Bio-Medical Electronics acquired 100 per cent of the issued and outstanding shares...
Shenzhen Mindray Bio-Medical Electronics’ €545 Million Acquisition Of Hytest Invest Oy
Freshfields Bruckhaus Deringer advised Shenzhen Mindray Bio-Medical Electronics Co., Ltd. on the deal. Shenzhen Mindray Bio-Medical Electronics acquired 100 per cent of the issued and outstanding shares...